These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22234107

  • 21. [Branhamella catarrhalis in respiratory infections].
    Marín Casanova P, García-Martos P, Fernández Fatou B, Bernal García F, Agudo Pérez E.
    Rev Clin Esp; 1989 May; 184(8):399-400. PubMed ID: 2506614
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie-Boulder, Western Australia.
    Pingault NM, Bowman JM, Lehmann D, Riley TV.
    Pathology; 2010 Apr; 42(3):273-9. PubMed ID: 20350222
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China.
    Shi W, Wen D, Chen C, Yuan L, Gao W, Tang P, Cheng X, Yao K.
    BMC Microbiol; 2018 Jul 20; 18(1):77. PubMed ID: 30029595
    [Abstract] [Full Text] [Related]

  • 26. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F, Lambert-Zechovsky N, Bingen E.
    Pathol Biol (Paris); 1993 Jun 20; 41(6):555-61. PubMed ID: 8247636
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC, McKenzie H.
    J Med Microbiol; 1997 May 20; 46(5):360-71. PubMed ID: 9152030
    [Abstract] [Full Text] [Related]

  • 30. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM, Suter M, Borsos S.
    J Antimicrob Chemother; 1999 Mar 20; 43 Suppl A():25-30. PubMed ID: 10225568
    [Abstract] [Full Text] [Related]

  • 31. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
    Sahm DF, Brown NP, Draghi DC, Evangelista AT, Yee YC, Thornsberry C.
    Postgrad Med; 2008 Sep 20; 120(3 Suppl 1):8-15. PubMed ID: 18931466
    [Abstract] [Full Text] [Related]

  • 32. [Antimicrobial susceptibility of 80 Moraxella catarrhalis strains isolated in the children's hospital of Tunis].
    Khemiri H, Smaoui H, Kechrid A.
    Pathol Biol (Paris); 2008 May 20; 56(3):158-61. PubMed ID: 18178028
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D, Ay-Altintop Y, Yagmur G, Gokahmetoglu S, Sumerkan B.
    Clin Microbiol Infect; 2007 Oct 20; 13(10):1023-5. PubMed ID: 17608812
    [Abstract] [Full Text] [Related]

  • 34. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J, Escoubas J, Fouche J, Mormede M.
    Pathol Biol (Paris); 1988 May 20; 36(5):540-3. PubMed ID: 3136431
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE, Heilmann KP, Richter SS, García-de-Lomas J, Doern GV, GRASP Study Group.
    Int J Antimicrob Agents; 2005 Feb 20; 25(2):148-56. PubMed ID: 15664485
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
    Sader HS, Gales AC, Granacher TD, Pfaller MA, Jones RN, SENTRY Study Group (Latin America).
    Braz J Infect Dis; 2000 Oct 20; 4(5):245-54. PubMed ID: 11063556
    [Abstract] [Full Text] [Related]

  • 37. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
    Liu Y, Xu H, Xu Z, Kudinha T, Fan X, Xiao M, Kong F, Sun H, Xu Y.
    Microb Drug Resist; 2015 Oct 20; 21(5):507-11. PubMed ID: 25923017
    [Abstract] [Full Text] [Related]

  • 38. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens.
    Alpuche C, Garau J, Lim V.
    Int J Antimicrob Agents; 2007 Dec 20; 30 Suppl 2():S135-8. PubMed ID: 17945468
    [Abstract] [Full Text] [Related]

  • 39. Distribution of genes encoding virulence factors ompB2, ompCD, ompE, β-lactamase and serotype in pathogenic and colonizing strains of Moraxella catarrhalis.
    Mitov IG, Gergova RT, Ouzounova-Raykova VV.
    Arch Med Res; 2010 Oct 20; 41(7):530-5. PubMed ID: 21167392
    [Abstract] [Full Text] [Related]

  • 40. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan.
    Inoue M, Kohno S, Kaku M, Yamaguchi K, Igari J, Yamanaka K.
    Int J Infect Dis; 2005 Jan 20; 9(1):27-36. PubMed ID: 15603993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.